Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development

Diagnostic strategy of diabetic polyneuropathy has progressed. In particular, Baba's classification on the severity of diabetic polyneuropathy using nerve conduction study and a point‐of‐care device of nerve conduction study will realize the objective quantitative evaluation of diabetic polyneu...

Descripción completa

Detalles Bibliográficos
Autores principales: Himeno, Tatsuhito, Kamiya, Hideki, Nakamura, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
JDI Updates
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944845/
https://www.ncbi.nlm.nih.gov/pubmed/31755662
http://dx.doi.org/10.1111/jdi.13188
_version_ 1783485085570301952
author Himeno, Tatsuhito
Kamiya, Hideki
Nakamura, Jiro
author_facet Himeno, Tatsuhito
Kamiya, Hideki
Nakamura, Jiro
author_sort Himeno, Tatsuhito
collection PubMed
description Diagnostic strategy of diabetic polyneuropathy has progressed. In particular, Baba's classification on the severity of diabetic polyneuropathy using nerve conduction study and a point‐of‐care device of nerve conduction study will realize the objective quantitative evaluation of diabetic polyneuropathy. [Image: see text]
format Online
Article
Text
id pubmed-6944845
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69448452020-01-09 Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development Himeno, Tatsuhito Kamiya, Hideki Nakamura, Jiro J Diabetes Investig JDI Updates Diagnostic strategy of diabetic polyneuropathy has progressed. In particular, Baba's classification on the severity of diabetic polyneuropathy using nerve conduction study and a point‐of‐care device of nerve conduction study will realize the objective quantitative evaluation of diabetic polyneuropathy. [Image: see text] John Wiley and Sons Inc. 2019-12-22 2020-01 /pmc/articles/PMC6944845/ /pubmed/31755662 http://dx.doi.org/10.1111/jdi.13188 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle JDI Updates
Himeno, Tatsuhito
Kamiya, Hideki
Nakamura, Jiro
Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
title Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
title_full Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
title_fullStr Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
title_full_unstemmed Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
title_short Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
title_sort diabetic polyneuropathy: progress in diagnostic strategy and novel target discovery, but stagnation in drug development
topic JDI Updates
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944845/
https://www.ncbi.nlm.nih.gov/pubmed/31755662
http://dx.doi.org/10.1111/jdi.13188
work_keys_str_mv AT himenotatsuhito diabeticpolyneuropathyprogressindiagnosticstrategyandnoveltargetdiscoverybutstagnationindrugdevelopment
AT kamiyahideki diabeticpolyneuropathyprogressindiagnosticstrategyandnoveltargetdiscoverybutstagnationindrugdevelopment
AT nakamurajiro diabeticpolyneuropathyprogressindiagnosticstrategyandnoveltargetdiscoverybutstagnationindrugdevelopment

Ejemplares similares